Skip to content

Evaluation of the effectiveness of biofeedback in patients with patellofemoral syndrome

Evaluation of the effect of biofeedback on pain relief and function in patients with patellofemoral syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180804040685N4
Enrollment
60
Registered
2022-02-09
Start date
2021-11-22
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patellofemoral pain syndrome. Patellofemoral disorders

Interventions

Intervention 1: Intervention group: Informed consent will be obtained from patients before entering the study. Demographic information of all patients including age, sex, BMI, duration of the disease

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of unilateral patellofemoral syndrome based on at least 5 of 7 symptoms There is no evidence of other injuries intra- and extra-arthicular of knee joint, which can be determined by physical examination and radiographic evaluation Normal range of motion of the knee as measured by a goniometer No history of knee trauma, intra-articular injection or surgery Do not use nonsteroidal anti-inflammatory drugs for 15 days before starting treatment Full collaboration to conduct the study

Exclusion criteria

Exclusion criteria: Having a pain score less than 3 on a numerical scale History of knee locking and patella dislocation Osteoarthritis or arthritis of the knee and any abnormal radiography of the knee Joint infection and knee ligamentous laxity History of previous knee physiotherapy, knee surgery, and knee injuries and bruises Genu valgum, Osgood-Schlatter disease, and any other pathological disease Any other treatment for patellofemoral syndrome during the study

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: Before the intervention, immediately and 3 months after the intervention. Method of measurement: Visual Analog Scale.;Satisfaction rate. Timepoint: Immediately and three months after the intervention. Method of measurement: Satisfaction rate questionnaire.;Quality of life. Timepoint: Before the intervention, immediately and 3 months after the intervention. Method of measurement: SF36 Questionnaire.;Daily performance. Timepoint: Before the intervention, immediately and 3 months after the intervention. Method of measurement: Kujala scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Reza Fateh

Tehran University of Medical Sciences

hr-fateh@tums.ac.ir+98 21 8940 2110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026